Arkolith/Insider Trading/DNTH/Form 4

Savitz Ryan

EVP, CFO & CBODianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Apr 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$739K
Net Open-Market Flow
-$739K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2026Option exercise(M)8K$17.88$147K8K
Apr 9, 2026Sell(S)8K$89.84$739K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 9, 2026Option exercise(M)8K—$072K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001992324-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML